Steve is Vice-President of Discovery Biology at AstraZeneca with responsibility for reagent generation and assay development, functional genomics, and cell and gene therapy. Previously Steve led the Screening Sciences department with accountability for Compound Management, Hit Discovery and Lead Optimisation biology. Prior to joining AstraZeneca, Steve worked at GlaxoSmithKline for 24 years. He has served as Chair of the European Laboratory Research and Innovation Group and Chair of the European council of the Society of Laboratory Automation and Screening and is Industry Trustee of the British Pharmacological Society. Steve was awarded an OBE in 2021 for services to science and the COVID19 response.

Steve Rees


Science, Industry and Translation CommitteeOctober 2022 - December 2025Member